AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Ondine D Eken

Appears inactive Last observed office action: March 2023 (36 months ago).

Examiner Ondine D Eken appears to be very difficult relative to their art unit, group, tech center, and USPTO peers. Their lifetime grant ratio is 0.0% and their rejection profile leans toward §103 and meaningful §101 activity.

Difficulty vs AU Very Hard
Difficulty vs Group Very Hard
Difficulty vs TC Very Hard
Difficulty vs USPTO Very Hard
Average OA / Grant N/A
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
2 years (2022-2023)
Tech Center
1600 - Biotechnology and Organic
Group
1670 - Virology and Related Immunology

Metrics

Applications Evaluated
4
Granted Applications
0
Non-Granted Applications
4
Avg OA / Grant
N/A
Last OA Observed
March 2023 (36 months ago)
Art Units Seen
1677 , 1678
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 0.0% N/A
Art Unit 14 22.1% 2.24
Group 80 29.9% 1.92
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2022 2023
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2022; examiner may not yet have been active in the available dataset.
2022 3 0 0.0%
2023 1 0 0.0%
No observed data after 2023; examiner may have gone inactive or moved out of examining work.

0 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 8 25.0% 12.5% 25.0% 0.0%
2 2 0.0% 50.0% 50.0% 0.0%
5 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

40.0%
2022
0.0%
2023

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.